NASDAQ:KURA

Kura Oncology SEC Filings & 10K Form

$26.15
+1.15 (+4.60 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.63
$26.23
50-Day Range
$24.76
$29.88
52-Week Range
$13.86
$43.00
Volume516,300 shs
Average Volume715,520 shs
Market Capitalization$1.73 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.15

SEC Filings

Kura Oncology (NASDAQ:KURA) SEC Filings

DateFilerForm TypeView
05/06/2021
3:11 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
3:19 PM
Kura Oncology (Filer)
Form DEFA14A
03/17/2021
3:17 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
11:08 AM
Kura Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2021
6:30 AM
Kura Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2021
6:25 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
7:09 AM
Avoro Capital Advisors LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G
02/11/2021
3:59 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/03/2021
1:29 PM
Kura Oncology (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
01/28/2021
4:31 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
4:29 PM
FLOWERS KIRSTEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
4:28 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
4:27 PM
DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
4:20 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
3:41 PM
Kura Oncology (Subject)
WILSON TROY EDWARD (Filed by)
Form SC 13G/A
01/08/2021
3:05 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
3:02 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
3:39 PM
Kura Oncology (Issuer)
Martell Bridget A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
3:04 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
3:03 PM
Kura Oncology (Filer)
Form 424B5
12/07/2020
3:24 PM
Kura Oncology (Filer)
Form 424B5
12/07/2020
3:03 PM
Kura Oncology (Filer)
Form S-3ASR
12/07/2020
5:08 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
5:08 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
3:04 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
4:02 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
6:46 AM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:40 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
10:23 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2020
5:55 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
6:25 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
6:23 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
6:22 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
5:05 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
5:04 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2020
5:24 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2020
5:22 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2020
3:25 PM
DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:38 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:05 AM
Kura Oncology (Filer)
Form 424B3
08/18/2020
11:15 PM
Kura Oncology (Filer)
Form EFFECT
08/11/2020
4:02 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:07 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
3:11 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:10 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:09 PM
Kura Oncology (Issuer)
Stein Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:08 PM
Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:07 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:06 PM
HOFFMAN ROBERT (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
7:16 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:34 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:31 PM
Kura Oncology (Filer)
Form 424B5
05/04/2020
3:17 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2020
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
3:15 PM
Kura Oncology (Filer)
Form DEFA14A
03/17/2020
7:19 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
10:46 AM
Kura Oncology (Filer)
Form CT ORDER
03/17/2020
10:43 AM
Kura Oncology (Filer)
Form CT ORDER
03/17/2020
10:39 AM
Kura Oncology (Filer)
Form CT ORDER
03/16/2020
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G
02/14/2020
3:20 PM
GREAT POINT PARTNERS LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/14/2020
1:31 PM
EcoR1 Capital, LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/12/2020
3:24 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
11:16 AM
BlackRock Inc. (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
01/31/2020
10:31 AM
Kura Oncology (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G
01/23/2020
3:36 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:00 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:05 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
3:10 PM
FLOWERS KIRSTEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
3:09 PM
FLOWERS KIRSTEN (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2019
9:39 AM
EAGLE ASSET MANAGEMENT INC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
12/16/2019
6:36 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
6:01 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
4:23 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
4:23 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/05/2019
3:16 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
8:01 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:07 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
3:06 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2019
7:00 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
7:02 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2019
11:15 PM
Kura Oncology (Filer)
Form EFFECT
08/28/2019
4:29 PM
Kura Oncology (Filer)
Form 424B3
08/21/2019
3:07 PM
Kura Oncology (Filer)
Form S-3/A
08/13/2019
5:17 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
5:16 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2019
3:12 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
3:37 PM
Kura Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/01/2019
3:16 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2019
3:04 PM
GUALBERTO ANTONIO (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
1:58 PM
FMR LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
06/27/2019
3:10 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:09 PM
Kura Oncology (Issuer)
Stein Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:07 PM
Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:06 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:05 PM
HOFFMAN ROBERT (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:01 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:03 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:02 PM
Kura Oncology (Filer)
Form 424B5
This page was last updated on 5/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.